Bracco S.p.A. — Bracco Imaging
Tracked across 3 events · 19 articles · First seen Apr 20, 2026 · Last active Sep 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Bracco S.p.A. — Bracco Imaging entered into a multi-year Master Research Agreement with NYU Langone Health to advance medical imaging innovation, which is expected to enhance its diagnostic solutions portfolio.
Apr 20, 2026 · 6 articles
Regulatory
Impact: Bracco S.p.A. — Bracco Imaging is the developer and manufacturer of VueJect, and the regulatory approvals enable its commercial launch in North America, supporting its CEUS ecosystem and growth strategy.
Aug 11, 2026 · 7 articles
Business
Bracco S.p.A. — Bracco Imaging, a global pharmaceutical company, announced the expansion of its BubbleGen cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit. The kit, built on Bracco's microbubble…
Impact: Bracco S.p.A. — Bracco Imaging is the developer and launcher of the BubbleGen CD3+ T Cell Selection Kit, expanding its product portfolio in cell therapy manufacturing. This launch could enhance its competitive position and future revenue streams.
Sep 09, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Bracco S.p.A. — Bracco Imaging live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard